References
- Mead GE, Lewis SC, Wardlaw JM, et al. Severe ipsilateral carotid stenosis and middle cerebral artery disease in lacunar ischaemic stroke: innocent bystanders? J Neurol. 2002;249:266–271. PubMed: 11993524.
- Potter G, Doubal F, Jackson C, et al. Associations of clinical stroke misclassification (‘clinical-imaging dissociation’) in acute ischemic stroke. Cerebrovasc Dis. 2010;29:395–402. PubMed: 20173323.
- Goldstein LB, Jones MR, Matchar DB, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001;32:1091–1098. PubMed: 11340215.
- Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701. PubMed: 20610345.
- Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–2089. PubMed: 23652265.
- Davis SM, Donnan GA. Why lacunar syndromes are different and important. Stroke. 2014;35:1779–1780. PubMed: 15166385.
- Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483–497. PubMed: 23602162.
- Knottnerus IL, Ten Cate H, Lodder J, et al. Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis. 2009;27:519–526. PubMed: 19372654.
- Wardlaw JM, Farrall A, Armitage PA, et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke. 2008;39:1327–1332. PubMed: 18309161.
- Thompson CS, Hakim AM. Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke. 2009;40:e322–e330. PubMed: 19228835.
- Redon J, Pascual JM. Development of microalbuminuria in essential hypertension. Curr Hypertens Rep. 2006;8:171–177. PubMed: 16672152.
- National Institute of Neurological Disorders and Stroke Committee. Special report from the national institute of neurological disorders and stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637–676. PubMed: 2326846.
- Bailey EL, Smith C, Sudlow CLM, et al. Pathology of lacunar ischaemic stroke in humans- a systematic review. Brain Pathol. 2012;22:583–591. PubMed: 22329603.
- O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200–204. PubMed: 15911742.
- Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341:c4249. PubMed: 20884696.
- Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke? J Neurol Sci. 2008;271:21–28. PubMed: 18514228.
- de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100–2105. PubMed: 16825327.
- Lee M, Saver JL, Chang KH, et al. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke. 2010;41:2625–2631. PubMed: 20930164.
- O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–123. PubMed: 20561675.
- Ninomiya T, Perkovic V, Verdon C, et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis. 2009;53:417–425. PubMed: 19070947.
- Makin SD, Cook FA, Dennis MS, et al. Cerebral small vessel disease and renal function: systematic review and meta-analysis. Cerebrovasc Dis. 2014;39:39–52. PubMed: 25547195.
- Putaala J, Haapaniemi E, Gordin D, et al. Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke. Stroke. 2011;42:2459–2464. PubMed: 21737795.
- Nidhinandana S, Chaisinanunkul N. The association between risk factors for ischemic stroke and microalbuminuria. J Med Assoc Thai. 2010;93(Suppl 6):S55–59. PubMed: 21280516.
- Di Raimondo D, Tuttolomondo A, Buttà C, et al. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des. 2012;18:4385–4413. PubMed: 22283779.
- Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. Int J Cardiol. 2011;151:318–322. PubMed: 20598761.
- Tuttolomondo A, Pecoraro R, Simonetta I, et al. Neurological complications of Anderson-Fabry disease. Curr Pharm Des. 2013;19:6014–6030. PubMed: 23448452.
- Tuttolomondo A, Pecoraro R, Simonetta I, et al. Anderson-Fabry disease: a multiorgan disease. Curr Pharm Des. 2013;19:5974–5996. PubMed: 23448451.
- Das P, Bhuiyan MM, Mia BA, et al. Urinary microalbumin as a risk factor for ischaemic stroke. Mymensingh Med J. 2012;21:709–714. PubMed: 23134922.